Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation.

Emile JF, Haddad E, Fraitag S, Canioni D, Fischer A, Brousse N.

Br J Haematol. 1997 Aug;98(2):480-4.

PMID:
9266954
2.

Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation.

Godthelp BC, van Eggermond MC, Peijnenburg A, Tezcan I, van Lierde S, van Tol MJ, Vossen JM, van den Elsen PJ.

Blood. 1999 Jul 1;94(1):348-58.

3.

Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.

Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, Lisowska-Grospierre B, Griscelli C, Fischer A.

Blood. 1995 Jan 15;85(2):580-7. Review.

4.

T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome.

Godthelp BC, Van Eggermond MC, Van Tol MJ, Vossen JM, van den Elsen PJ.

Hum Immunol. 2000 Sep;61(9):898-907.

PMID:
11053633
5.

Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.

De Villartay JP, Griscelli C, Fischer A.

Eur J Immunol. 1986 Feb;16(2):117-22.

PMID:
3514234
6.

Residual expression of functional MHC class II molecules in twin brothers with MHC class II deficiency is cell type specific.

Wolf HM, Thon V, Gulle H, Lechleitner S, Eibl MM, Petzelbauer P.

Br J Haematol. 2001 Nov;115(2):460-71.

PMID:
11703350
7.

Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.

Knutsen AP, Wall DA.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):823-32.

PMID:
10329816
8.

Epidermal Langerhans cells after allogeneic bone marrow transplantation: depletion by chemotherapy conditioning regimen alone.

Zambruno G, Girolomoni G, Manca V, Andreani M, Galimberti M, Lucarelli G, Giannetti A.

J Cutan Pathol. 1992 Jun;19(3):187-92.

PMID:
1383297
9.

Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.

Sloane JP, Thomas JA, Imrie SF, Easton DF, Powles RL.

J Clin Pathol. 1984 Aug;37(8):919-30.

10.

Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival.

Popitz-Bergez FA, Sakamoto K, Pennington LR, Pescovitz MD, McDonough MA, MacVittie TJ, Gress RE, Sachs DH.

Transplantation. 1988 Jan;45(1):27-31.

PMID:
3122386
11.

Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease.

Perreault C, Pelletier M, Belanger R, Boileau J, Bonny Y, David M, Gyger M, Landry D, Montplaisir S.

Br J Haematol. 1985 Jun;60(2):253-60.

PMID:
3890932
12.

Allogeneic bone marrow transplantation: relation between chimaerism and immunity.

Vossen J.

Verh K Acad Geneeskd Belg. 1998;60(2):111-43; discussion 143-5. Review.

PMID:
9703764
16.

Epithelial class II antigen expression in cutaneous graft-versus-host disease.

Beschorner WE, Farmer ER, Saral R, Stirling WL, Santos GW.

Transplantation. 1987 Aug;44(2):237-43.

PMID:
3307048
17.
18.

Epidermal Langerhans' cells in children with primary T-cell immune deficiencies.

Emile JF, Durandy A, Le Deist F, Fischer A, Brousse N.

J Pathol. 1997 Sep;183(1):70-4.

PMID:
9370950
19.

Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection.

Gonçalves MA, Soares EG, Fernandes AP, Fonseca BA, Bettini JS, Simões RT, Donadi EA.

Eur J Obstet Gynecol Reprod Biol. 2004 Jun 15;114(2):221-7.

PMID:
15140519
20.

Supplemental Content

Support Center